City

Genk (1)

Melbourne (1)

Condition

Drug Abuse, Intravenous (4)

Foreign Bodies (1)

Hepatitis C (1)

Internet (1)

Needle Injury (1)

Social Media (1)

Soft Tissue Injuries (1)

Substance Dependence (1)

Telemedicine (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Unknown status (1)

Phase

n/a (1)

phase 3 (1)

Sponsor

Hasselt University (1)

Macfarlane Burnet Institute for Medical Research and Public Health Ltd (1)

State University of New York at Buffalo (1)

Tampere University Hospital (1)

Collaborator

A-Clinic Foundation (1)

CAD Limburg (1)

Deaconess Foundation (1)

Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases (1)

St Vincent's Hospital Melbourne (1)

Ziekenhuis Oost-Limburg (1)

Intervention

case management (1)

focus group discussions and survey questionnaire (1)

low-dose x-ray of subcutaneous tissues (1)

sofosbuvir/ledispasvir fixed dose combination (sof + ldp) (1)

Study Documents

Intervention Type

other (2)

drug (1)

radiation (1)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (2)

drug abuse, intravenous

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Telemedicine and Social Media for People Who Inject Drugs in

Not yet recruiting

Drug Abuse, Intravenous
+3 more

Focus group discussions and survey questionnaire

(no location specified)

Mar 20, 2023

Retained Drug Needle Fragments in People Who Use Intravenous

Not yet recruiting

Drug Abuse, Intravenous
+4 more

Low-dose X-ray of subcutaneous tissues

(no location specified)

Jan 9, 2023

Drug Abuse, Intravenous Trial in Genk (case management)

Completed

Drug Abuse, Intravenous

case management

Genk, Belgium

Ziekenhuis Oost-Limburg

Jan 23, 2020

Hepatitis C, Drug Abuse, Intravenous Trial in Melbourne (Sofosbuvir/ledispasvir fixed dose combination (SOF + LDP))

Unknown status

Hepatitis C
Drug Abuse, Intravenous

Sofosbuvir/ledispasvir fixed dose combination (SOF + LDP)

Melbourne, Victoria, Australia

Burnet Institute

Apr 8, 2018